-
-
- Aug 5/26
Artificial cells reveal how living cells take shape through giant blebs - Aug 5/26
Virus-like particles deliver gene-editing tools into Duchenne mouse model - Aug 4/26
How CRISPR-edited donor islet cells are opening a path toward a functional cure for type 1 diabetes - Aug 4/26
How transposable elements adapt in clinically important adult stem cells - Aug 4/26
AI framework aids target discovery for CAR T cell therapy - Aug 3/26
UCLA scientists build ‘cell villages’ to map the genetics of brain cell fitness - Aug 3/26
Biogen’s Salanersen shows potential to address unmet needs in spinal muscular atrophy - Aug 3/26
This Week’s CGT News: Gene-Editing Trial Death Raises Concerns - Aug 3/26
Researchers identify immune “off switch” exploited by cancer cells - Aug 2/26
Weekly reads: FDA warning, Capricor pub vs. AdCom, stem cells can count, hydra regeneration - Jul 30/26
FDA AdCom shuns Capricor’s DMD cell therapy amid data dispute - Jul 30/26
The next phase of diabetes cell therapy and islet transplantation - Jul 30/26
J&J secures right to take the helm in up to $925M Sail CAR T pact - Jul 30/26
Musings from The Power List: Claudia Zylberberg - Jul 30/26
Scientists at UMass Chan Medical School develop microRNA-based gene therapy that halts ALS progression in mice - Jul 29/26
Teen walks independently after treatment targets the genetic root of epilepsy - Jul 29/26
Donor cord blood composition may influence CAR NK cell therapy outcomes - Jul 29/26
The BioPharm Brief: Designations, Decisions, and Data - Jul 28/26
Phenotypic and functional characterization of CAR-T cells to support robust cell therapy research - Jul 28/26
Leadership changes afoot at two CGT biotechs - Jul 28/26
Blood must flow: How pushing and pulling forces shape our blood vessels - Jul 27/26
Relapsed or refractory multiple myeloma: Early-phase trial investigates novel bispecific antibody - Jul 27/26
This Week’s CGT News: Off-the-shelf CAR T tackles kidney cancer - Jul 26/26
Weekly reads: MYC phosphorylation, reverse protein aging, mitochondria don’t like space, that peptide committee - Jul 26/26
HMN 2026: How sound waves guide cultured cells to form vessel-like networks within one week - Jul 24/26
Mass-producible immune cells kill patient-derived colorectal tumours in mice - Jul 23/26
Four takeaways from our investigation into a hidden gene-editing death - Jul 21/26
Canada has the science. Does it have the strategy to be a life sciences power? - Jul 21/26
Stem cell therapy for GA shows early evidence of vision gains, retina preservation - Jul 21/26
Personalized gene therapy helps teen with rare form of severe epilepsy walk independently - Jul 20/26
This Week’s CGT News: First-in-human diabetes cell therapy - Jul 20/26
Kolon’s cell-based gene therapy fails phase 3 osteoarthritis trial - Jul 20/26
Scalable cell therapy manufacturing: Shifting from research to GMP - Jul 16/26
Human embryo models (SCBEM) are powerful but probably won’t get a Nobel; lessons about rewards in science - Jul 16/26
New technology identifies differences and conditions in culture media for cell biomanufacturing - Jul 15/26
Immune cells use previously unknown pathway to eliminate AML - Jul 15/26
Gene therapy reverses fragile X traits in preclinical study - Jul 15/26
Sound waves guide formation of engineered tissues - Jul 14/26
CAR T cell therapy shows promise for myelofibrosis - Jul 14/26
Steer Bio targets lymphedema with regenerative cell therapy platform - Jul 14/26
Novel CAR T cell therapy offers promising option for hard-to-treat kidney cancer - Jul 14/26
The BioPharm Brief: Reduction, relief and reach - Jul 14/26
Let’s stop treating allogeneic cell therapy as one thing - Jul 13/26
This week’s CGT news: Radiopharmaceutical boosts CAR T - Jul 13/26
Universal 6iL/E4 system enables stem cell growth across mammals - Jul 13/26
In vivo CAR T: A new route to treating autoimmune disease - Jul 13/26
The first human trial to reverse aging just Got FDA clearance: What epigenetic reprogramming actually is - Jul 13/26
Smart cellular bricks: When physical modules learn to recognize and repair themselves - Jul 12/26
Weekly reads: Colossal Bio & Trump admin partnership, FDA commish finalists, appetite-regulating neurons - Jul 10/26
First clinical trial of stem cell therapy for Huntington’s disease announced - Jul 9/26
New genetic screen advances understanding of human development - Jul 9/26
RoslinCT partners with BlueRock Therapeutics to expand access to clinical-grade stem cell lines - Jul 8/26
Endless supply of cancer-fighting immune cells unlocked by USC scientists - Jul 8/26
Novel strategy can make stem cell transplants safer - Jul 8/26
New gene therapy strategy uses the brain’s own glymphatic transport system for drug delivery - Jul 7/26
Why Canada needs to build its biomanufacturing capacity - Jul 7/26
Breakthrough diabetes treatment reprograms the immune system instead of replacing insulin - Jul 7/26
This Week’s CGT News: First Treg Therapy Approved - Jul 7/26
UCLA research team awarded millions to bring new MS therapy to trial - Jul 7/26
Two MSL faculty awarded 2026 NSERC Funding - Jul 6/26
FDA expands Casgevy label to children as young as 2, broadening access to first CRISPR gene therapy for sickle cell disease - Jul 6/26
Scientists build living ‘neurobots’ that grow their own neural networks - Jul 5/26
Weekly reads: Claude Science AI in biology & scientist obsolescence, Orca Bio gets FDA nod, Neanderthal genes - Jul 3/26
UniXell secures FDA clearance for iPSC-derived Parkinson’s cell therapy - Jul 2/26
Post-BIO ins and outs: Rentschler and Syngene CEO appointments among big moves - Jul 2/26
‘Mind blowing’: Wearable devices detect CRS hours earlier among CAR-T recipients - Jul 2/26
Novartis receives European Commission approval for Itvisma for spinal muscular atrophy - Jul 2/26
Breakthrough immunotherapy offers hope in combatting fatal brain tumours - Jul 1/26
CAR T cell therapy targets crucial mutation behind rare blood cancers - Jul 1/26
Advanced imaging technology unlocks exosome potential for disease diagnosis - Jul 1/26
Reinforced bilayer membranes boost bone regeneration - Jul 1/26
FDA approves Tregzi for adults with hematological malignancies - Jun 30/26
First-of-its-kind cell therapy clinical trial led by Children’s National shows promising long-term survival in children with aggressive brain tumours - Jun 29/26
FDA’s top gene therapy regulator is leaving his role - Jun 28/26
Weekly reads: more FDA flexibility on rare diseases, elephant iPS cells, heritable human CRISPR, RTT rarely used, digit regeneration - Jun 25/26
Newer gene therapies, tested at Columbia, could give sickle cell patients more options - Jun 25/26
AI framework aids target discovery for CAR T cell therapy - Jun 24/26
HMN 2026: How stem cell transplantation is found to be more cost-effective than gene therapy for sickle cell disease - Jun 24/26
New technology uncovers how the heart produces cells with regenerative potential - Jun 24/26
Can printed ‘skin’ heal burns and prevent scars? - Jun 24/26
Feeling bullish over FDA changes, Regenxbio solidifies filing plans for Duchenne gene therapy - Jun 24/26
Scientists may have discovered how to heal damaged kidneys - Jun 24/26
Antler stem cells relieve cerebral ischemic injury - Jun 24/26
RFK Jr. , stem cells for autism, & more clinics including one selling sheep cell injections - Jun 24/26
Organizing digital systems around novel modalities - Jun 23/26
First patient receives neural stem cell therapy in groundbreaking UCI Health Huntington’s disease clinical trial - Jun 23/26
Canada’s biotech moment: Where scientific depth is meeting commercial scale - Jun 23/26
Menstrual blood repairs cartilage in osteoarthritis tissue - Jun 23/26
Can scientists learn cells’ language? UCLA-led team aims to decode cellular conversations - Jun 22/26
New progenitor cell platform offers scalable source for immunotherapy - Jun 22/26
Direct inoculation of bioreactors with cryopreserved stem cells - Jun 21/26
Weekly reads: FDA reversal on Huntington’s, Marjorie Taylor Greene gets stem cells, NIH grant cap, eye evolution - Jun 21/26
Creatine may improve cancer immunotherapy by energizing immune cells - Jun 19/26
Gene therapy for deadly childhood liver disease - Jun 18/26
At FDA, ‘caretaker mode’ is better than power trip mode - Jun 18/26
Gene therapy reverses Fragile X deficits in mice - Jun 18/26
Integrating quality by design principles into gene-therapy CMC programs: Establishing manufacturing control and comparability
- Aug 5/26
-
